Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Can Repellents Prevent Malaria in Africa?
ISRCTN ISRCTN92202008
ClinicalTrials.gov identifier
Public title Can Repellents Prevent Malaria in Africa?
Scientific title Low cost repellents for use in rural Africa: a short-term efficacy, effectiveness and perceived benefit survey in Kilombero, Tanzania
Acronym CRPMA
Serial number at source NIMR/HQ/R8a/VolIX/780
Study hypothesis As Tanzania progresses towards the goals of the Abuja declaration and insecticide-treated bed nets (ITN) coverage becomes almost universal, there is likely to be a selection pressure on malaria mosquitoes to feed outdoors and earlier in the evening when hosts are available. This coupled with changes in lifestyle such as increased access to electricity so people stay awake later means that the relative exposure of the population to infectious mosquito bites is likely to switch to earlier in the evening. A topical insect repellent containing deet can dramatically reduce malaria in South America and Southern Asia where vectors feed early in the evening. The project aims to measure the impact of such a repellent on clinical episodes of malaria in rural Africa.
Lay summary
Ethics approval 1. Ifakara Health Institute Institutional Review Board approved on the 10th November 2008 (ref: IHRDC/IRB/No. A46)
2. National Institute of Medical Research, Tanzania, approved on the 6th March 2009 (ref: NIMR/HQ/R8a/VolIX/780)
Study design Cluster controlled randomised trial
Countries of recruitment Tanzania
Disease/condition/study domain Malaria
Participants - inclusion criteria Household head over 18 years, either sex
Participants - exclusion criteria Under six months of age
Anticipated start date 30/08/2009
Anticipated end date 30/07/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 4819
Interventions Long lasting insecticide treated nets (Olyset) + 15% deet repellent
Long lasting insecticide treated nets (Olyset) + placebo lotion

Total duration of intervention: 44 weeks
Total duration of follow-up: 1 month after the trial ends
Primary outcome measure(s) 1. Malaria incidence
2. Clinical episodes of malaria

Data is continually collected on a daily basis through passive case detection at a local clinic throughout the trial.
Secondary outcome measure(s) Malaria prevalence.

Data is continually collected on a daily basis through passive case detection at a local clinic throughout the trial.
Sources of funding Population Services International (PSI) (Tanzania) - Innovations Grant
Trial website
Publications
Contact name Dr  Sarah  Moore
  Address Disease Control and Vector Biology Unit (DCVBU)
London School of Hygiene and Tropical Medicine
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
  Email sarah.moore@lshtm.ac.uk
Sponsor Ifakara Health Institute (Tanzania)
  Address Box 53
  City/town Ifakara
  Zip/Postcode 53
  Country Tanzania
  Sponsor website: http://www.ihi.or.tz/
Date applied 29/01/2010
Last edited 18/02/2010
Date ISRCTN assigned 18/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central